Table 2

Spread and Evolution of Respiratory Syncytial Virus A Genotype ON1, Coastal Kenya, 2010–2015

James R. Otieno

, Everlyn M. Kamau, Charles N. Agoti, Clement Lewa, Grieven Otieno, Ann Bett, Mwanajuma Ngama, Patricia A. Cane, and D. James Nokes

Author affiliations: Kenya Medical Research Institute (KEMRI)–Wellcome Trust Research Programme, Kilifi, Kenya (J.R. Otieno, E.M. Kamau, C.N. Agoti, C. Lewa, G. Otieno, A. Bett, M. Ngama, D.J. Nokes); Pwani University, Kilifi (C.N. Agoti); Public Health England, Salisbury, UK (P.A. Cane); University of Warwick, Coventry, UK (D.J. Nokes)

Main Article

Clinical severity comparison between cases of pneumonia caused by respiratory syncytial virus A genotypes ON1 and GA2 in children admitted to Kilifi County Hospital, September 2010–August 2015*

Characteristic	Unadjusted odds ratio (95% CI)	p value
Age <1 y	0.85 (0.49–1.49)	0.579
Male sex	0.76 (0.52–1.12)	0.172
Clinical features
Cough	1.16 (0.31–4.37)	0.830
Breathing difficulty	0.28 (0.08–0.97)	0.045
Chest wall indrawing	1.46 (0.46–4.59)	0.520
Inability to feed	2.40 (1.31–4.36)	0.004
Oxygen saturation <90%	0.86 (0.53–1.38)	0.521
Prostration/unconsciousness	1.67 (0.75–3.74)	0.211
Pneumonia status, very severe	0.89 (0.57–1.39)	0.609
Hospital stay, >4 d	0.77 (0.53–1.14)	0.192
Outcome, died	1.416 (0.42–4.78)	0.575

*The denominator was 442 samples but for some of the features it ranged from 439 to 442.

Main Article

Page created: January 17, 2017

Page updated: January 17, 2017

Page reviewed: January 17, 2017

The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.